24/7 Wall St. on MSN45m
Why Tempus AI (TEM) Is Soaring Today
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...
GEN52m
Recursion Announces Promising Clinical Data on Lead AI-Based Drug Candidate for Brain Disease
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.